IL6 and peripheral arterial disease: Greater the exposure of the biomarkers IL-6 and IL-8 has resulted in a collection of research data on the role of interleukins (ILs) in PAD, specifically in relation to glycoproteins acting as proinflammatory substances that influence blood vessel walls when atherosclerotic plaque development is initiated and how it develops.